BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17573124)

  • 1. Impact of HMG-CoA reductase inhibition on brain pathology.
    Zipp F; Waiczies S; Aktas O; Neuhaus O; Hemmer B; Schraven B; Nitsch R; Hartung HP
    Trends Pharmacol Sci; 2007 Jul; 28(7):342-9. PubMed ID: 17573124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?
    Schönbeck U; Libby P
    Circulation; 2004 Jun; 109(21 Suppl 1):II18-26. PubMed ID: 15173059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol homeostasis and the pathophysiology of Alzheimer's disease.
    Blain JF; Poirier J
    Expert Rev Neurother; 2004 Sep; 4(5):823-9. PubMed ID: 15853509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins--a cure-all for the brain?
    Menge T; Hartung HP; Stüve O
    Nat Rev Neurosci; 2005 Apr; 6(4):325-31. PubMed ID: 15803163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease.
    Reiss AB; Siller KA; Rahman MM; Chan ES; Ghiso J; de Leon MJ
    Neurobiol Aging; 2004 Sep; 25(8):977-89. PubMed ID: 15212822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoprenoids and Alzheimer's disease: a complex relationship.
    Cole SL; Vassar R
    Neurobiol Dis; 2006 May; 22(2):209-22. PubMed ID: 16406223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans.
    Farooqui AA; Ong WY; Horrocks LA; Chen P; Farooqui T
    Brain Res Rev; 2007 Dec; 56(2):443-71. PubMed ID: 17959252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins as potential therapeutic agents in neuroinflammatory disorders.
    Stüve O; Youssef S; Steinman L; Zamvil SS
    Curr Opin Neurol; 2003 Jun; 16(3):393-401. PubMed ID: 12858078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward immunomodulatory and anti-inflammatory properties of statins.
    Arnaud C; Braunersreuther V; Mach F
    Trends Cardiovasc Med; 2005 Aug; 15(6):202-6. PubMed ID: 16182129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins in stroke: prevention, protection and recovery.
    Switzer JA; Hess DC
    Expert Rev Neurother; 2006 Feb; 6(2):195-202. PubMed ID: 16466299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do statins slow down Alzheimer's disease? A review.
    Caballero J; Nahata M
    J Clin Pharm Ther; 2004 Jun; 29(3):209-13. PubMed ID: 15153082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration?
    Guymer RH; Chiu AW; Lim L; Baird PN
    Surv Ophthalmol; 2005; 50(2):194-206. PubMed ID: 15749309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does statin use decrease the amount of Alzheimer disease pathology in the brain?
    Silbert LC
    Neurology; 2007 Aug; 69(9):E8-11. PubMed ID: 17724280
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic potential of statins in Alzheimer's disease.
    Kandiah N; Feldman HH
    J Neurol Sci; 2009 Aug; 283(1-2):230-4. PubMed ID: 19321181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).
    Fritz G
    Int J Oncol; 2005 Nov; 27(5):1401-9. PubMed ID: 16211237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
    Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
    Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential roles for statins in critically ill patients.
    Weant KA; Cook AM
    Pharmacotherapy; 2007 Sep; 27(9):1279-96. PubMed ID: 17723082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins: the next anti-endotoxin.
    Kruger PS
    Crit Care Resusc; 2006 Sep; 8(3):223-6. PubMed ID: 16930109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin-mediated protective effects in the central nervous system: general mechanisms and putative role of stress proteins.
    Schmeer C; Kretz A; Isenmann S
    Restor Neurol Neurosci; 2006; 24(2):79-95. PubMed ID: 16720944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and autoimmune diseases.
    Gurevich VS; Shovman O; Slutzky L; Meroni PL; Shoenfeld Y
    Autoimmun Rev; 2005 Mar; 4(3):123-9. PubMed ID: 15823497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.